SCHEMBL7797647

SCHEMBL7797647

CCOC(=O)C(CC(=O)c1ccc(Cl)cc1Cl)(NC=O)C(=O)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.46
MAPT P10636 5/20 0.46
KDM4E B2RXH2 3/20 0.46
ALOX12 P18054 2/20 0.46
HPGD P15428 2/20 0.46
GAA P10253 1/20 0.46
PKM P14618 1/20 0.46
MAPK1 P28482 1/20 0.43
HIF1A Q16665 1/20 0.43
TDP1 Q9NUW8 3/20 0.43
ERCC5 P28715 1/20 0.43
FEN1 P39748 1/20 0.43
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CRHBP P24387 1/20 0.42
CRHR2 Q13324 1/20 0.42
NPC1 O15118 1/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8656066 0.94 ALDH1A1 (0.46) ALDH1A1MAPTKDM4EALOX12HPGD
SCHEMBL7797580 0.91 ERCC5 (0.43) ALDH1A1MAPTKDM4EALOX12HPGD
SCHEMBL7791499 0.87 CNR2 (0.41) ALDH1A1MAPTKDM4EALOX12HPGD
SCHEMBL7799510 0.85 LMNA (0.47) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL8654757 0.85 ERCC5 (0.43) ALDH1A1MAPTKDM4EALOX12HPGD
SCHEMBL7799547 0.83 SMN1; SMN2 (0.45) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL7800768 0.81 MAPT (0.44) ALDH1A1MAPTHPGDGAAPKM
SCHEMBL7797586 0.80 MAPT (0.45) ALDH1A1MAPTKDM4EHPGDPKM
SCHEMBL7797584 0.78 ERCC5 (0.42) ALDH1A1GAAPKMERCC5FEN1
SCHEMBL7797652 0.77 L3MBTL1 (0.46) ALDH1A1MAPTKDM4EHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT ALDH1A1 615/4885MAPT 206/4885KDM4E 122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.